Zivo Bioscience, Inc.
ZIVO- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001101026
No open-market purchases or sales by Zivo Bioscience, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $17.6K in total; no superinvestor holds it.
Holders of 5% or more of ZIVO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Zivo Bioscience, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Hep Investments LLC | 13D/A | 17.80%488.8K shares | – | Mar 14, 20241 filing | Mar 14, 2024 | SEC |
| Strome Mezzanine Fund, LP | 13D/A | 12.20%442.9K shares | – | Jan 7, 20251 filing | Jan 7, 2025 | SEC |
| Strome Mark E | 13D/A | 12.10%472.9K shares | – | Feb 27, 20261 filing | Feb 27, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Zivo Bioscience, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 27, 20268:20 PM ET | Strome Mark Eand 4 others | 13D/A | 12.10%472.9K shares | – | Dec 31, 2025 | SEC |
| Jan 7, 20256:01 PM ET | Strome Mezzanine Fund, LPand 4 others | 13D/A | 12.20%442.9K shares | – | Dec 26, 2024 | SEC |
| Mar 14, 20249:16 AM ET | Hep Investments LLCand 1 other | 13D/A | 17.80%488.8K shares | – | Dec 5, 2023 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Zivo Bioscience, Inc. shares.
No Form 144 notices for Zivo Bioscience, Inc. are on file.